ELYSIA
ActiveSummary
ELYSIA has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.58M and a net result of €129k. Equity is growing by ~3.7% per year across the filed fiscal years. Its solvency ranks better than 55% of 179 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
67
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability59▲+40
Solvency70▲+4
Growth79▲+19
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €230k at 30 days acceptable
Liquidity tight (current ratio 1.36 against 1.37 in 2024; short-term debt: 46.9% and cash: 2.9% of total assets), and 55.3% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 74
Relative position
BE, all sectors
reference
Sector 74
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
44.7%
Return on assets
1.6%
Age of the figures
15 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 28-11-2025, 64 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
64 d early
2024
74 d early
2023
14 d early
2022
33 d early
2021
62 d early
2020
17 d early
2019
64 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close24-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€12.48M▲ 21.8%
2024 · €10.25M
2019: €5.60M
2020: €5.76M
2021: €6.56M
2022: €7.37M
2023: €9.16M
2024: €10.25M
2019 → 2025
EBIT margin
2.1%▲ 6.8pp
2024 · -4.6%
2019: -5.6%
2020: -4.0%
2021: -1.5%
2022: 4.2%
2023: 0.1%
2024: -4.6%
2019 → 2025
Net result
€129k
2024 · €-619k
2019: €-356k
2020: €-155k
2021: €-46k
2022: €280k
2023: €-6k
2024: €-619k
2019 → 2025
Working capital
€1.34M▼ 13.6%
2024 · €1.56M
2019: €956k
2020: €746k
2021: €2.09M
2022: €2.76M
2023: €2.26M
2024: €1.56M
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€6.56M-€7.37M▲ 12.4%€9.16M▲ 24.2%€10.25M▲ 11.9%€12.48M▲ 21.8%
Equity€3.62M-€3.90M▲ 7.7%€3.89M▼ 0.2%€3.45M▼ 11.4%€3.58M▲ 3.7%
Operating result€-97k-€312k€12k▼ 96.0%€-476k€268k
Net result€-46k-€280k€-6k€-619k▼ 10,293%€129k
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €268k after a loss of €476k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €8.00M
Fixed assets
€2.90M ▲ 9.5%
Current assets
€5.10M ▼ 11.8%
Equity and liabilities €8.00M
Equity
€3.58M ▲ 3.7%
Debt
€4.42M ▼ 11.2%
Debt's share of the balance-sheet total falls from 59.1% to 55.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€962k▲
2024 · €150k
Cash flow
€823k▲
2024 · €7k
Current ratio
1.36▼
2024 · 1.37
Quick ratio
0.98▼
2024 · 1.05
Debt to equity
1.24▼
2024 · 1.44
ROE
3.6%▲
2024 · -18.0%
ROA
1.6%▲
2024 · -7.3%
Interest coverage
5.15▲
2024 · 0.78
Debt ≤ 1 year
€3.75M▼
2024 · €4.22M
Debt > 1 year
€175k▼
2024 · €350k
Income taxes
€-26k▲
2024 · €-40k
Staff costs
€2.34M▲
2024 · €2.19M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 62 lines
Balance sheet
Code20242025
Assets
Total assets20/58€8.43M€8.00M▼
Formation expenses20€0€0=
Fixed assets21/28€2.65M€2.90M▲
Intangible fixed assets21€1.86M€2.05M▲
Tangible fixed assets22/27€98k€79k▼
Land and buildings22€0-
Plant, machinery and equipment23€28k€34k▲
Furniture and vehicles24€45k€20k▼
Other tangible fixed assets26€25k€25k▲
Financial fixed assets28€692k€769k▲
Current assets29/58€5.78M€5.10M▼
Amounts receivable after more than one year29€101k€118k▲
Other amounts receivable291€101k€118k▲
Stocks and contracts in progress3€1.35M€1.41M▲
Stocks30/36€1.35M€1.41M▲
Amounts receivable within one year40/41€3.77M€3.09M▼
Trade receivables40€3.36M€2.87M▼
Other amounts receivable41€416k€224k▼
Current investments50/53€2k€2k▲
Cash at bank and in hand54/58€258k€232k▼
Deferred charges and accrued income490/1€289k€241k▼
Equity and liabilities
Total equity and liabilities10/49€8.43M€8.00M▼
Equity10/15€3.45M€3.58M▲
Contributions10/11€4.79M€4.79M=
Capital10€4.79M€4.79M=
Issued capital100€4.79M€4.79M=
Profit (loss) carried forward14€-1.35M€-1.22M▲
Investment grants15€0€0=
Amounts payable17/49€4.98M€4.42M▼
Amounts payable after more than one year17€350k€175k▼
Financial debts170/4€256k€81k▼
Other amounts payable178/9€94k€94k=
Amounts payable within one year42/48€4.22M€3.75M▼
Current portion of amounts payable after more than one year42€209k€212k▲
Financial debts43€1.50M€1.50M▼
Credit institutions430/8€1.50M€803k▼
Other loans439-€697k
Trade debts44€1.32M€1.74M▲
Suppliers440/4€1.32M€1.74M▲
Taxes, remuneration and social security45€218k€298k▲
Taxes450/3€159€26k▲
Remuneration and social security454/9€218k€273k▲
Other amounts payable47/48€968k€6k▼
Accrued charges and deferred income492/3€411k€497k▲
Income statement
Code20242025
Turnover70€10.25M€12.48M▲
Goods, raw materials, services and sundry goods60/61€8.89M€10.03M▲
Remuneration, social security and pensions62€2.19M€2.34M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€626k€694k▲
Other operating charges640/8€99k€49k▼
Gross operating margin9900€2.44M€3.35M▲
Operating profit (loss)9901€-476k€268k▲
Financial income75/76B€10k€21k▲
Recurring financial income75€10k€21k▲
Financial charges65/66B€193k€187k▼
Recurring financial charges65€193k€187k▼
Profit (loss) for the period before taxes9903€-659k€103k▲
Income taxes67/77€-40k€-26k▲
Profit (loss) for the period9904€-619k€129k▲
Profit (loss) for the period to be appropriated9905€-619k€129k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-1.35M€-1.22M▲
Profit (loss) brought forward from the previous period14P€-729k€-1.35M▼
Social balance
Average headcount (FTE)908725.625.0▼
The notes to these accounts (21 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
11-09
State Gazette act
Resignations: Nomainvest SA, Bio Consult GMBH and 6 othersPermanent representatives: Bernard Jolly, Daniel Bartholemy and 5 others · Appointments: John Clapham, Peter Clapham and 4 others · Mandate compensation30 facts ▸
State Gazette act
Resignations: Nomainvest SA, Bio Consult GMBH and 6 others
Permanent representatives: Bernard Jolly, Daniel Bartholemy and 5 others · Appointments: John Clapham, Peter Clapham and 4 others · Mandate compensation30 facts ▸
- General meeting, 31-07-2026
- Director resignation, Nomainvest SA (director)
- Permanent representative, Bernard Jolly
- Director resignation, Bio Consult GMBH (director)
- Permanent representative, Daniel Bartholemy
- Director resignation, Bioinnovas AG (director)
- Permanent representative, Jörg Schlegel
- Director resignation, Noshaq Partners SRL (director)
- Permanent representative, Patrick Stragier
- Director resignation, Inventures SA (director)
- Permanent representative, Olivier de Duve
- Director resignation, Xovelis SRL (director)
- +18 further facts in this act
2025
28-11
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
30-06
Financial
Back to profitnet €129k
Net result €129k after 2 loss-making years.
2024
18-11
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
30-06
Financial
Weakest financial yearnet €-619k
Net result drops to €-619k, the lowest in the series; recovery starts the following year.
17-01
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2022
29-12
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
30-06
Financial
Back to profitnet €280k
Net result €280k after 3 loss-making years.
2021
30-11
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
14-01
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2019
28-11
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2018
22-11
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2017
19-12
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
19-01
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
under verification, no change since 2026
This board is reconstructed from a single act (26114672). A Gazette act generally publishes only CHANGES, not a full roll call, so directors unchanged since then may be missing here. The KBO register holds the complete list of function holders.
John Clapham
CurrentDirector · since 31-07-2026
Kieran Crow
CurrentDirector · since 31-07-2026
Peter Clapham
CurrentDirector · since 31-07-2026
Richard Brown
CurrentDirector · since 31-07-2026
Tom Deakin
CurrentDirector · since 31-07-2026
Xovelis SRL
CurrentDirector · since 31-07-2026 · Legal entity · perm. rep.: François Moonen
31-07-2026
John Clapham: Appointed as Director
31-07-2026
Kieran Crow: Appointed as Director
31-07-2026
Peter Clapham: Appointed as Director
31-07-2026
Richard Brown: Appointed as Director
31-07-2026
Tom Deakin: Appointed as Director
Location & real-estate footprint
Registered office, Seraing · 1 establishment unit since 2014
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue du Bois St-Jean 234102 Seraing1 establishment unit
ELYSIA
since 20142.230.490.056
Public money · subsidies and aid
European research
1 project · 256,320 EUR EU contributionProgrammes
Horizon 2020
Projects
PET Imaging of Alpha-Synuclein Fibril Formation
Recognitions · licences · registrations
Legal Entity Identifier
699400CD0NQWQIGGXU76
Similar companies · same sector, comparable size
Lam Research Belgium
BE 0561.862.008
Leuven · Eq €3.61M
Link Office
BE 0836.023.994
Dison · Eq €3.50M
IMMO WAGLAS
BE 0425.387.956
Sint-Niklaas · Eq €3.72M
JuuNoo
BE 0666.679.020
Anzegem · Eq €3.42M
ENERGY EXPERTISE
BE 0898.341.645
Aubel · Eq €3.78M
Of 4,567 companies in sector 74999 we hold annual accounts for 1,938. 365 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded02-05-2014
Fiscal year end30-06
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
74999Other professional, scientific and technical activities
27900Manufacture of electrical equipment
Sources
Crossroads Bank for EnterprisesNational Bank · 11 filings
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
4 entriesE-mail:info@elysia-raytest.com
E-mail:investors@elysia-raytest.com
Website:www.elysia-raytest.com
Phone:+32 4 243 43 50